RX BANDZ, INC. — FA301623C0060 — Federal Contract Award | GovChime

PIID: FA301623C0060 • Signed: Mar 14, 2025AWARDDEFINITIVE CONTRACTSmall Business

MEDICAL RESEARCH AND DEVELOPMENT - SBIR II TACFI

Total Obligated:$1,799,613

Overview

Total Obligated

$1,799,613

Potential Value

$1,799,613

Transactions

Contract Details

PIID:

FA301623C0060

Award Type:

DEFINITIVE CONTRACT

Award/IDV:AWARD

Pricing Type:FIRM FIXED PRICE

Date Signed:Mar 14, 2025

Fiscal Year:2025

Period of Performance:Sep 18, 2023 - Sep 18, 2025

Potential End Date:Sep 17, 2025

Modification #:P00002

Multi-year Contract:YES

Performance-Based Service:YES - SERVICE WHERE PBA IS USED.

Financial Breakdown

Base + Exercised Options:$0

Base + All Options:$0

Description of Requirement

MEDICAL RESEARCH AND DEVELOPMENT - SBIR II TACFI

Awardee Information

Name

UEIDXRED7S6FVE9

CAGE Code7N2K8

Business SizeSMALL BUSINESS

Cong. DistrictTX-25

Address

1605 LAKECLIFF HILLS LN STE 100, AUSTIN, TX, 787322437

Certifications

Women Owned

Parent Company

NameRX BANDZ, INC.

UEIDXRED7S6FVE9

Agency & Location

Contracting Agency

DepartmentDepartment of Defense

Sub-tier AgencyDepartment Of The Air Force

Contracting OfficeFA3016 502 CONS CL

Funding Agency

DepartmentDepartment of Defense

Sub-tier AgencyDepartment Of The Air Force

Funding OfficeF4FBEQ AFRL RGF

Place of Performance

AUSTIN, TRAVIS, TEXAS, 787322437, UNITED STATES

Congressional District: TX-25

Classification & Competition

Classification Codes

NAICS Code

541715

RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)

PSC Code

AJ12

GENERAL SCIENCE AND TECHNOLOGY R&D SERVICES; GENERAL SCIENCE AND TECHNOLOGY; APPLIED RESEARCH

Competition Information

Extent CompetedFULL AND OPEN COMPETITION AFTER EXCLUSION OF SOURCES

Solicitation ProceduresNEGOTIATED PROPOSAL/QUOTE

Set-Aside Type

SMALL BUSINESS SET ASIDE - TOTAL

Number of Offers1

Transaction History

Mod #	Action Date	Obligation Change	Cumulative Total	Reason
P00002	Mar 14, 2025	+$0	$1,799,613	-
P00001	Sep 21, 2023	+$0	$1,799,613	-
0	Sep 16, 2023	+$1,799,613	$1,799,613	-